"Delta Plus is a variant of interest, but not a variant of concern. It has not yet been classified as a variant of concern, in which there is adverse consequence to humanity. As per data available in the public domain, this variant nullifies the use of monoclonal antibody. We will scientifically study and learn more about this variant.